INNERDYNE INC
425, 2000-11-27
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: VARIABLE ACCOUNT I OF AIG LIFE INS CO, N-4/A, EX-4.(I), 2000-11-27
Next: INNERDYNE INC, SC 14D9/A, 2000-11-27




                        Filed by Tyco International Ltd.
              Pursuant to Rule 425 Under the Securities Act of 1933
                         Filer: Tyco International Ltd.
                        Subject Company: InnerDyne, Inc.
            File Number for Related Registration Statement: 333-48180


FOR IMMEDIATE RELEASE
(Monday, November 27, 2000)



CONTACTS:
TYCO:
Investor Relations                          Media Relations
J. Brad McGee                               Judith Czelusniak
Executive Vice President,                   Senior Vice President,
Chief Strategy Officer                      Corporate Relations
Tyco International (US) Inc.                Tyco International (US) Inc.
(603) 778-9700                              (561) 988-7424

INNERDYNE:
William G. Mavity
President/CEO
InnerDyne, Inc.
(408) 745-6010


                  SEC DECLARES REGISTRATION STATEMENT EFFECTIVE
                          FOR INNERDYNE EXCHANGE OFFER

PEMBROKE, Bermuda and SUNNYVALE, Calif., November 27, 2000 -- Tyco International
Ltd. (NYSE:  TYC; LSE: TYI; BSX: TYC), a diversified  manufacturing  and service
company,  and  InnerDyne,  Inc.  (Nasdaq:  IDYN),  a  medical  manufacturer  and
distributor  of  patented  radial  dilating  access  devices  used in  minimally
invasive  surgical  procedures,  today  announced  that  the  Security  Exchange
Commission has declared effective Tyco's registration  statement relating to the
exchange offer of Tyco Acquisition Corp. X for the common stock of InnerDyne.

Tyco  Acquisition  is offering  to  exchange a fraction  of a Tyco common  share
valued at $7.50,  determined as described in the prospectus  for the offer,  for
each share of InnerDyne  common stock. The offer is scheduled to expire at 12:00
midnight on Wednesday, November 29, 2000.

<PAGE>

ABOUT INNERDYNE
InnerDyne designs,  develops and manufactures minimally invasive surgical access
products that incorporate the company's  proprietary radial dilation technology,
including  the patented  Step(TM)  expandable  needle  system.  Radial  dilation
provides  surgical  access  through  expansion  of a very  small  opening  using
progressively larger blunt instruments.

ABOUT TYCO INTERNATIONAL
Tyco is a diversified  manufacturing  and service  company.  Tyco is the world's
largest manufacturer and servicer of electrical and electronic  components;  the
world's  largest  designer,  manufacturer,  installer  and  servicer of undersea
telecommunications  systems;  the world's  largest  manufacturer,  installer and
provider of fire protection systems and electronic  security  services,  and the
world's  largest  manufacturer  of flow control  valves.  Tyco also holds strong
leadership  positions in disposable medical products,  diagnostic imaging,  bulk
pharmaceuticals,  wound closure,  plastics and adhesives.  Tyco operates in more
than 100 countries  and has reported  fiscal 2000 sales of  approximately  $28.9
billion.

Tyco has filed a registration statement on Form S-4, a Schedule TO, a prospectus
and other  documents  relating to the exchange offer and InnerDyne has filed the
related  solicitation/recommendation  statement on Schedule  14D-9 with the SEC.
Copies of these  documents and other  documents filed by Tyco and InnerDyne with
the SEC may be  obtained  at the  SEC's  web site at  http://www.sec.gov.  These
documents may also be obtained from Tyco or from InnerDyne by directing requests
to Tyco International Ltd., The Zurich Centre,  Second Floor, 90 Pitts Bay Road,
Pembroke HM 08,  Bermuda,  tel:  (441)  292-8674;  or to InnerDyne,  Inc.,  1244
Reamwood Avenue, Sunnyvale, CA 94089, tel: (408) 745-6010.

Documents may also be obtained from MacKenzie  Partners,  Inc., the  information
agent for the offer, 156 Fifth Avenue,  New York, New York 10010, (212) 929-5500
(call collect) or (800) 322-2885 (toll free).

                                       ###




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission